| 1 | 1 | | I |
|---|
| 2 | 2 | | 119THCONGRESS |
|---|
| 3 | 3 | | 1 |
|---|
| 4 | 4 | | STSESSION H. R. 795 |
|---|
| 5 | 5 | | To prohibit the Department of Health and Human Services from treating |
|---|
| 6 | 6 | | pregnancy as an illness for purposes of approving abortion drugs. |
|---|
| 7 | 7 | | IN THE HOUSE OF REPRESENTATIVES |
|---|
| 8 | 8 | | JANUARY28, 2025 |
|---|
| 9 | 9 | | Mrs. M |
|---|
| 10 | 10 | | ILLERof Illinois (for herself, Mr. BABIN, Mr. MOOREof West Virginia, |
|---|
| 11 | 11 | | Mr. O |
|---|
| 12 | 12 | | GLES, Mr. WEBSTERof Florida, Ms. TENNEY, Mr. HARRISof |
|---|
| 13 | 13 | | Maryland, and Mr. W |
|---|
| 14 | 14 | | EBERof Texas) introduced the following bill; which |
|---|
| 15 | 15 | | was referred to the Committee on Energy and Commerce |
|---|
| 16 | 16 | | A BILL |
|---|
| 17 | 17 | | To prohibit the Department of Health and Human Services |
|---|
| 18 | 18 | | from treating pregnancy as an illness for purposes of |
|---|
| 19 | 19 | | approving abortion drugs. |
|---|
| 20 | 20 | | Be it enacted by the Senate and House of Representa-1 |
|---|
| 21 | 21 | | tives of the United States of America in Congress assembled, 2 |
|---|
| 22 | 22 | | SECTION 1. SHORT TITLE. 3 |
|---|
| 23 | 23 | | This Act may be cited as the ‘‘Pregnancy Is Not an 4 |
|---|
| 24 | 24 | | Illness Act of 2025’’. 5 |
|---|
| 25 | 25 | | VerDate Sep 11 2014 22:15 Feb 24, 2025 Jkt 059200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H795.IH H795 |
|---|
| 26 | 26 | | ssavage on LAPJG3WLY3PROD with BILLS 2 |
|---|
| 27 | 27 | | •HR 795 IH |
|---|
| 28 | 28 | | SEC. 2. PROHIBITION AGAINST TREATING PREGNANCY AS 1 |
|---|
| 29 | 29 | | ILLNESS FOR PURPOSES OF APPROVING 2 |
|---|
| 30 | 30 | | ABORTION DRUGS. 3 |
|---|
| 31 | 31 | | (a) P |
|---|
| 32 | 32 | | ROHIBITION.—The Department of Health and 4 |
|---|
| 33 | 33 | | Human Services, including the Food and Drug Adminis-5 |
|---|
| 34 | 34 | | tration, shall not treat pregnancy as an illness for pur-6 |
|---|
| 35 | 35 | | poses of— 7 |
|---|
| 36 | 36 | | (1) approving any abortion drug under section 8 |
|---|
| 37 | 37 | | 505 of the Federal Food, Drug, and Cosmetic Act 9 |
|---|
| 38 | 38 | | (21 U.S.C. 355); or 10 |
|---|
| 39 | 39 | | (2) imposing or maintaining any risk evaluation 11 |
|---|
| 40 | 40 | | and mitigation strategy for an abortion drug under 12 |
|---|
| 41 | 41 | | section 505–1 of such Act (21 U.S.C. 355–1). 13 |
|---|
| 42 | 42 | | (b) N |
|---|
| 43 | 43 | | ULLIFICATION OFAPPROVALS INEFFECT.— 14 |
|---|
| 44 | 44 | | (1) I |
|---|
| 45 | 45 | | N GENERAL.—Any prohibited approval of 15 |
|---|
| 46 | 46 | | an abortion drug is hereby nullified. 16 |
|---|
| 47 | 47 | | (2) P |
|---|
| 48 | 48 | | ROHIBITED APPROVAL DEFINED .—In this 17 |
|---|
| 49 | 49 | | subsection, the term ‘‘prohibited approval of an 18 |
|---|
| 50 | 50 | | abortion drug’’— 19 |
|---|
| 51 | 51 | | (A) means any approval of an abortion 20 |
|---|
| 52 | 52 | | drug under section 505 of the Federal Food, 21 |
|---|
| 53 | 53 | | Drug, and Cosmetic Act (21 U.S.C. 355) that 22 |
|---|
| 54 | 54 | | relied in whole or in part on the treatment of 23 |
|---|
| 55 | 55 | | pregnancy as illness; and 24 |
|---|
| 56 | 56 | | VerDate Sep 11 2014 22:15 Feb 24, 2025 Jkt 059200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H795.IH H795 |
|---|
| 57 | 57 | | ssavage on LAPJG3WLY3PROD with BILLS 3 |
|---|
| 58 | 58 | | •HR 795 IH |
|---|
| 59 | 59 | | (B) includes the approval of mifepristone 1 |
|---|
| 60 | 60 | | in effect under such section 505 on the day be-2 |
|---|
| 61 | 61 | | fore the date of enactment of this Act. 3 |
|---|
| 62 | 62 | | Æ |
|---|
| 63 | 63 | | VerDate Sep 11 2014 22:15 Feb 24, 2025 Jkt 059200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6301 E:\BILLS\H795.IH H795 |
|---|
| 64 | 64 | | ssavage on LAPJG3WLY3PROD with BILLS |
|---|